MIS-C: A Case Study

Medical

MIS-C is a recently recognized illness in children which is associated with COVID-19 infection. The full spectrum of the disease is not yet clear and therefore it is necessary understand the characteristics of this syndrome. I have come across a child diagnosed with MIS-C. A 12-year-old male with nor previous significant medical history was brought to hospital with the chief complaints of joint pain since 3 days with difficulty in walking, fever since 2 days (fever to 103°F), abdominal pain and the child has not passed stools since 2 days. Other clinical features were running nose, facial puffiness, abdominal bloating, lethargy, weakness, shortness of breath. The vital signs were checked and found that temperature, pulse and respiratory rate were increased. The Oxygen saturation was 95% when brought to emergency department. Laboratory values showed that there was Leukocytosis(152000/cmm), thrombocytopenia(135000/cmm), hyponatremia(128.55 mm/L), and hypokalemia(3.2 mm/L). CRP (C-reactive protein) was elevated(201.20 mg/dL), and an elevated D-dimers level (1086 ng ml), the anti SARS-CoV-2 antibody was reactive and RT-PCR (reverse-transcription polymerase chain reaction) was negative. MRI study of pelvis with both hip joints revealed Grade-I sprain/edema involving ligamentum capitis femoris/ ligamentum teres of right hip joint with mild right hip joint effusion. The child was administered intravenous antibiotics (Ceftriaxone 2gm, bd), intravenous steroids (Methylprednisolone 500mg, od), antiallergic medication ( Pheniramine maleate 1mg. sos), analgesic (Diclofenac sodium, 75mg, TDS). Other medications included antacids, antiemetics and DNS with MVI for a total of 5 days. Then supportive treatment was given and was discharged home after 7 days of hospital stay.

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.